✦ LIBER ✦

Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer

✍ Scribed by Rodrigo Dienstmann, Felipe Ades, Kamal S. Saini, Otto Metzger-Filho

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in the treatment of breast c

✍ Angelos K. Koutras; George Fountzilas; Thomas Makatsoris; Stavros Peroukides; Ha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Bevacizumab in the Treatment of Metastat

✍ Cianfrocca, Mary; Gradishar, William J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Review of bevacizumab in the treatment o

✍ Volker Heinemann 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Bevacizumab in the first-line treatment

✍ David Cameron 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Bevacizumab in First-Line Treatment of M

✍ David Miles 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 46 KB

Bevacizumab in First-Line Treatment of M

✍ Xavier Pivot 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 45 KB